LigaChem Biosciences Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 141080.KQ | BIOCON.NS | 196170.KQ | 207940.KS | 2269.HK | 1548.HK | |
|---|---|---|---|---|---|---|
| Market cap | 2.63T | 548.65B | 16.71T | 65.97T | 203.35B | 78.27B |
| P/E (TTM) | — | 99.1 | — | — | 37.1 | — |
| Forward P/E | — | 30.6 | — | — | 22.7 | 87.5 |
| Price/book | — | 1.6 | — | — | 3.6 | 2.5 |
| Dividend yield | — | 0.15% | 0.12% | — | — | — |
| 1-year change | −48.68% | −7.13% | −33.49% | −20.92% | +38.95% | +106.04% |
| Today | +2.00% | −1.47% | +3.90% | +1.87% | −1.30% | +2.69% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 141080.KQ news ›LigaChem Biosciences Doses First Patient in Trial of ADC "LCB02A" Targeting Gastric, Pancreatic Cancers
Published 16 Oct.2026 08:40(KST) LigaChem Biosciences has begun global clinical trials of LCB02A, a candidate antibody-drug conjugate (ADC) targeting Claudin 18.2 (CLDN18.2) that it developed in-house. LigaChem Biosciences said on October…
Pharma and Biotech Stocks Surge in Tandem... Celltrion Up 6%, LigaChem Biosciences Up 8%
South Korean pharmaceutical and biotech stocks surged across the board in domestic trading. The rally was driven by concentrated buying as the healthcare sector led gains on Wall Street overnight, compounded by positive clinical results…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
en.sedaily.com1
-
finance.biggo.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.